FDAnews Drug Daily Bulletin

ALTUS PHARMACEUTICALS REPORTS FIRST QUARTER 2006 RESULTS

May 16, 2006
A A

Altus Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, today reported financial results for the first three months ended March 31, 2006. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1550437)